<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34287033</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Coinfections with Other Respiratory Pathogens among Patients with COVID-19.</ArticleTitle><Pagination><StartPage>e0016321</StartPage><MedlinePgn>e0016321</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.00163-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/Spectrum.00163-21</ELocationID><Abstract><AbstractText>Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individuals are at an increased risk for coinfections; therefore, physicians need to be cognizant about excluding other treatable respiratory pathogens. Here, we report coinfection with SARS-CoV-2 and other respiratory pathogens in patients admitted to the coronavirus disease (COVID) care facilities of an Indian tertiary care hospital. From June 2020 through January 2021, we tested 191 patients with SARS-CoV-2 for 33 other respiratory pathogens using an fast track diagnostics respiratory pathogen 33 (FTD-33) assay. Additionally, information regarding other relevant respiratory pathogens was collected by reviewing their laboratory data. Overall, 13 pathogens were identified among patients infected with SARS-CoV-2, and 46.6% (89/191) of patients had coinfection with one or more additional pathogens. Bacterial coinfections (41.4% [79/191]) were frequent, with Staphylococcus aureus being the most common, followed by Klebsiella pneumoniae. Coinfections with SARS-CoV-2 and Pneumocystis jirovecii or Legionella pneumophila were also identified. The viral coinfection rate was 7.3%, with human adenovirus and human rhinovirus being the most common. Five patients in our cohort had positive cultures for Acinetobacter baumannii and K. pneumoniae, and two patients had active Mycobacterium tuberculosis infection. In total, 47.1% (90/191) of patients with coinfections were identified. The higher proportion of patients with coinfections in our cohort supports the systemic use of antibiotics in patients with severe SARS-CoV-2 pneumonia with rapid de-escalation based on respiratory PCR/culture results. The timely and simultaneous identification of coinfections can contribute to improved health of COVID-19 patients and enhanced antibiotic stewardship during the pandemic. <b>IMPORTANCE</b> Coinfections in COVID-19 patients may worsen disease outcomes and need further investigation. We found that a higher proportion of patients with COVID-19 were coinfected with one or more additional pathogens. A better understanding of the prevalence of coinfection with other respiratory pathogens in COVID-19 patients and the profile of pathogens can contribute to effective patient management and antibiotic stewardship during the current pandemic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sreenath</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batra</LastName><ForeName>Priyam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinayaraj</LastName><ForeName>E V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Ridhima</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>SaiKiran</LastName><ForeName>Kvp</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Vishwajeet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sheetal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Hospital Administration, National Cancer Institute, Jhajjar, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Nishant</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Urvashi B</ForeName><Initials>UB</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Anant</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatnagar</LastName><ForeName>Sushma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Onco-Anaesthesia and Palliative Medicine, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trikha</LastName><ForeName>Anjan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guleria</LastName><ForeName>Randeep</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>Rama</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciencesgrid.413618.9, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D040981" MajorTopicYN="N">Acinetobacter baumannii</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000260" MajorTopicYN="N">Adenoviruses, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073602" MajorTopicYN="N">Antimicrobial Stewardship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007711" MajorTopicYN="N">Klebsiella pneumoniae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coinfections</Keyword><Keyword MajorTopicYN="N">multiple-pathogen testing</Keyword><Keyword MajorTopicYN="N">respiratory PCR</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>21</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34287033</ArticleId><ArticleId IdType="pmc">PMC8552727</ArticleId><ArticleId IdType="doi">10.1128/Spectrum.00163-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team . 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727&#x2013;733. doi:10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner L. 2020. An interactive Web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20:533&#x2013;534. doi:10.1016/S1473-3099(20)30120-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, et al.. 2020. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382:1787&#x2013;1799. doi:10.1056/NEJMoa2001282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001282</ArticleId><ArticleId IdType="pmc">PMC7121492</ArticleId><ArticleId IdType="pubmed">32187464</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, Doosti Z, Golzari SEJ. 2020. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis 20:646. doi:10.1186/s12879-020-05374-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05374-z</ArticleId><ArticleId IdType="pmc">PMC7461753</ArticleId><ArticleId IdType="pubmed">32873235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Wang CY, Hsueh PR. 2020. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect 53:505&#x2013;512. doi:10.1016/j.jmii.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7245213</ArticleId><ArticleId IdType="pubmed">32482366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsburg AS, Klugman KP. 2020. COVID-19 pneumonia and the appropriate use of antibiotics. Lancet Glob Health 8:e1453&#x2013;e1454. doi:10.1016/S2214-109X(20)30444-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30444-7</ArticleId><ArticleId IdType="pmc">PMC7833845</ArticleId><ArticleId IdType="pubmed">33188730</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L, Lim B, Baskaran V, Lim WS. 2020. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 81:266&#x2013;275. doi:10.1016/j.jinf.2020.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey BW, Jayathilake K, Meltzer HY. 2020. Respiratory microbial co-infection with SARS-CoV-2. Front Microbiol 11:2079. doi:10.3389/fmicb.2020.02079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.02079</ArticleId><ArticleId IdType="pmc">PMC7477285</ArticleId><ArticleId IdType="pubmed">32983056</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrel S, Hausfater P, Dres M, Pourcher V, Luyt C-E, Teyssou E, Souli&#xe9; C, Calvez V, Marcelin A-G, Boutolleau D. 2021. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int J Infect Dis 102:10&#x2013;13. doi:10.1016/j.ijid.2020.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.040</ArticleId><ArticleId IdType="pmc">PMC7585729</ArticleId><ArticleId IdType="pubmed">33115679</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, Hu T, Li J, Zhou X, Ren B. 2020. The microbial co-infection in COVID-19. Appl Microbiol Biotechnol 104:7777&#x2013;7785. doi:10.1007/s00253-020-10814-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-020-10814-6</ArticleId><ArticleId IdType="pmc">PMC7417782</ArticleId><ArticleId IdType="pubmed">32780290</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy J-PR, Daneman N. 2020. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 26:1622&#x2013;1629. doi:10.1016/j.cmi.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.016</ArticleId><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DSC, Du B, Li L-J, Zeng G, Yuen K-Y, Chen R-C, Tang C-L, Wang T, Chen P-Y, Xiang J, Li S-Y, Wang J-L, Liang Z-J, Peng Y-X, Wei L, Liu Y, Hu Y-H, Peng P, Wang J-M, Liu J-Y, Chen Z, Li G, Zheng Z-J, Qiu S-Q, Luo J, Ye C-J, Zhu S-Y, Zhong N-S, China Medical Treatment Expert Group for Covid-19 . 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708&#x2013;1720. doi:10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. 2020. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ 98:442&#x2013;442A. doi:10.2471/BLT.20.268573.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.20.268573</ArticleId><ArticleId IdType="pmc">PMC7375214</ArticleId><ArticleId IdType="pubmed">32742026</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana S, Singh P, Sharad N, Kiro VV, Rastogi N, Lathwal A, Malhotra R, Trikha A, Mathur P. 2020. Profile of co-infections &amp; secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: implication on antimicrobial resistance. Indian J Med Microbiol 39:147&#x2013;153. doi:10.1016/j.ijmmb.2020.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmmb.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7667411</ArticleId><ArticleId IdType="pubmed">33966856</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Management Protocol: COVID-19 Government of India Ministry of Health and Family Welfare Directorate General of Health Services (EMR Division) (Version 5, 03.07.20). 2020. NATIONAL CLINICAL MANAGEMENT PROTOCOL COVID-19 (mohfw.gov.in).</Citation></Reference><Reference><Citation>Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, Peng Z, Pan H. 2020. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 127:104364. doi:10.1016/j.jcv.2020.104364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104364</ArticleId><ArticleId IdType="pmc">PMC7194884</ArticleId><ArticleId IdType="pubmed">32311650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Quinn J, Pinsky B, Shah NH, Brown I. 2020. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 323:2085&#x2013;2086. doi:10.1001/jama.2020.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6266</ArticleId><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Contou D, Claudinon A, Pajot O, Mica&#xeb;lo M, Flandre PL, Dubert M, Cally R, Logre E, Fraiss&#xe9; M, Mentec H, Plantef&#xe8;ve G. 2020. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care 10:119. doi:10.1186/s13613-020-00736-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00736-x</ArticleId><ArticleId IdType="pmc">PMC7475952</ArticleId><ArticleId IdType="pubmed">32894364</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, Ng O-T, Marimuthu K, Ang LW, Mak TM, Lau SK, Anderson DE, Chan KS, Tan TY, Ng TY, Cui L, Said Z, Kurupatham L, Chen MI-C, Chan M, Vasoo S, Wang L-F, Tan BH, Lin RTP, Lee VJM, Leo Y-S, Lye DC, for the Singapore 2019 Novel Coronavirus Outbreak Research Team . 2020. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 323:1488&#x2013;1494. doi:10.1001/jama.2020.3204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3204</ArticleId><ArticleId IdType="pmc">PMC7054855</ArticleId><ArticleId IdType="pubmed">32125362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, Zhu F, Zhu B, Cui L. 2020. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res 285:198005. doi:10.1016/j.virusres.2020.198005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198005</ArticleId><ArticleId IdType="pmc">PMC7213959</ArticleId><ArticleId IdType="pubmed">32408156</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Jia X, Zhang X, Ling Y, Yi Z. 2021. Co-infection in COVID-19, a cohort study. J Infect 8:414&#x2013;451. doi:10.1016/j.jinf.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7543684</ArticleId><ArticleId IdType="pubmed">33039502</ArticleId></ArticleIdList></Reference><Reference><Citation>Westmeier J, Paniskaki K, Karak&#xf6;se Z, Werner T, Sutter K, Dolff S, Overbeck M, Limmer A, Liu J, Zheng X, Brenner T, Berger MM, Witzke O, Trilling M, Lu M, Yang D, Babel N, Westhoff T, Dittmer U, Zelinskyy G. 2020. Impaired cytotoxic CD8+ T cell response in elderly COVID-19 patients. mBio 11:e002243-20. doi:10.1128/mBio.02243-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02243-20</ArticleId><ArticleId IdType="pmc">PMC7502863</ArticleId><ArticleId IdType="pubmed">32948688</ArticleId></ArticleIdList></Reference><Reference><Citation>Anton-Vazquez V, Clivill&#xe9; R. 2021. Streptococcus pneumoniae co-infection in hospitalised patients with COVID-19. Eur J Clin Microbiol Infect Dis 40:1353&#x2013;1355. doi:10.1007/s10096-021-04166-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-021-04166-w</ArticleId><ArticleId IdType="pmc">PMC7813618</ArticleId><ArticleId IdType="pubmed">33462723</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukamoto T, Nakajima N, Sakurai A, Nakajima M, Sakurai E, Sato Y, Takahashi K, Kanno T, Kataoka M, Katano H, Iwata M, Doi Y, Suzuki T. 2021. Lung pathology of mutually exclusive co-infection with SARS-CoV-2 and Streptococcus pneumoniae. Emerg Infect Dis 27:919&#x2013;923. doi:10.3201/eid2703.204024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2703.204024</ArticleId><ArticleId IdType="pmc">PMC7920656</ArticleId><ArticleId IdType="pubmed">33443011</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreenath K, Chaudhry R, Vinayaraj EV, Dey AB, Kabra SK, Thakur B, Guleria R. 2020. Distribution of virulence genes and sequence-based types among Legionella pneumophila isolated from the water systems of a tertiary care hospital in India. Front Public Health 8:596463. doi:10.3389/fpubh.2020.596463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.596463</ArticleId><ArticleId IdType="pmc">PMC7719716</ArticleId><ArticleId IdType="pubmed">33330340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreenath K, Dey AB, Kabra SK, Thakur B, Guleria R, Chaudhry R. 2020. Legionella pneumophila in patients with pneumonia at a referral hospital, New Delhi, India, 2015-2020. Am J Trop Med Hyg 154:854&#x2013;860. doi:10.4269/ajtmh.20-0653.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0653</ArticleId><ArticleId IdType="pmc">PMC7941854</ArticleId><ArticleId IdType="pubmed">33319733</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry R, Sreenath K, Vinayaraj EV, Sahoo B, Vishnu Narayanan MR, Sai Kiran KVP, Batra P, Rathor N, Singh S, Mohan A, Bhatnagar S. 2021. Mycoplasma pneumoniae co-infection with SARS-CoV-2: a case report. Access Microbiol 3:000212. doi:10.1099/acmi.0.000212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/acmi.0.000212</ArticleId><ArticleId IdType="pmc">PMC8209699</ArticleId><ArticleId IdType="pubmed">34151164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Wu Q, Xu W, Qiao B, Wang J, Zheng H, Jiang S, Mei J, Wu Z, Deng Y, Zhou F, Wu W, Zhang Y, Lv Z, Huang J, Guo X, Feng L, Xia Z, Li D, Xu Z, Liu T, Zhang P, Tong Y, Li Y. 2020. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv. 10.1101/2020.02.12.20022327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.12.20022327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozaras R, Cirpin R, Duran A, Duman H, Arslan O, Bakcan Y, Kaya M, Mutlu H, Isayeva L, Kebanl&#x131; F, Deger BA, Bekeshev E, Kaya F, Bilir S. 2020. Influenza and COVID-19 co-infection: report of six cases and review of the literature. J Med Virol 92:2657&#x2013;2665. doi:10.1002/jmv.26125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26125</ArticleId><ArticleId IdType="pubmed">32497283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Lu P, Fan Y, Xia Y, Liu M. 2020. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 92:1549&#x2013;1555. doi:10.1002/jmv.25781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25781</ArticleId><ArticleId IdType="pmc">PMC7228290</ArticleId><ArticleId IdType="pubmed">32196707</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothe K, Feihl S, Schneider J, Walln&#xf6;fer F, Wurst M, Lukas M, Treiber M, Lahmer T, Heim M, Dommasch M, Waschulzik B, Zink A, Querbach C, Busch DH, Schmid RM, Schneider G, Spinner CD. 2021. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis 40:859&#x2013;869. doi:10.1007/s10096-020-04063-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04063-8</ArticleId><ArticleId IdType="pmc">PMC7605734</ArticleId><ArticleId IdType="pubmed">33140176</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AJ, Jackson MS, Bagg J. 2001. The ecology of Staphylococcus species in the oral cavity. J Med Microbiol 50:940&#x2013;946. doi:10.1099/0022-1317-50-11-940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-50-11-940</ArticleId><ArticleId IdType="pubmed">11699589</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal C, Przydzial P, Chika-Nwosuh O, Shah S, Patel P, Madan N. 2020. Streptococcus pneumoniae coinfection in COVID-19: a series of three cases. Case Rep Pulmonol 2020:8849068. doi:10.1155/2020/8849068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8849068</ArticleId><ArticleId IdType="pmc">PMC7729390</ArticleId><ArticleId IdType="pubmed">33343959</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon AA, Berg DD, Brea EJ, Deutsch AJ, Kidia KK, Thurber EG, Polsky SB, Yeh T, Duskin JA, Holliday AM, Gay EB, Fredenburgh LE. 2020. A case of COVID-19 and Pneumocystis jirovecii coinfection. Am J Respir Crit Care Med 202:136&#x2013;138. doi:10.1164/rccm.202003-0766LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0766LE</ArticleId><ArticleId IdType="pmc">PMC7328312</ArticleId><ArticleId IdType="pubmed">32412848</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcari G, Raponi G, Sacco F, Bibbolino G, Di Lella FM, Alessandri F, Coletti M, Trancassini M, Deales A, Pugliese F, Antonelli G, Carattoli A. 2021. Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital. Int J Antimicrob Agents 57:106245. doi:10.1016/j.ijantimicag.2020.106245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106245</ArticleId><ArticleId IdType="pmc">PMC7691820</ArticleId><ArticleId IdType="pubmed">33253903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoda T, Harada S, Okamoto K, Ishino S, Kaneko M, Suzuki M, Ito R, Mizoguchi M. 2021. COVID-19 and fatal sepsis caused by hypervirulent Klebsiella pneumoniae, Japan, 2020. Emerg Infect Dis 27:556&#x2013;559. doi:10.3201/eid2702.204662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.204662</ArticleId><ArticleId IdType="pmc">PMC7853555</ArticleId><ArticleId IdType="pubmed">33320080</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman T, Fedorowsky R, Yerushalmi R, Lellouche J, Nutman A. 2021. An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital. Infect Prev Pract 3:100113. doi:10.1016/j.infpip.2021.100113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.infpip.2021.100113</ArticleId><ArticleId IdType="pmc">PMC7794049</ArticleId><ArticleId IdType="pubmed">34316574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>